Artículos por temáticas

Editorial for "Association of Myelin Disruption and Iron Accumulation on MRI With Parkinson's Disease Severity"

Roberts AG, Şişman M, Dimov AV.

J Magn Reson Imaging. 2025 Oct;62(4):1117-1118. doi: 10.1002/jmri.70002. Epub 2025 Jun 8.

Author Correction: Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases

Ali M, Erabadda B, Chen Y, Xu Y, Gong K, Liu M, Pichet Binette A, Timsina J, Western D, Yang C, Heo G, Vogel JW, Tijms BM, Krish V, Imam F; Global Neurodegeneration Proteomics Consortium (GNPC); Hanss

Nat Med. 2025 Oct;31(10):3569. doi: 10.1038/s41591-025-03970-7.

A Systematic Review and Meta-Analysis of Non-Invasive Nerve Stimulation Interventions on Dysphagia in Patients with Parkinson's Disease

Wang P, Huo H, Zhang Y, Zhang Q, Tan X, Zhang S, Wang D.

Neuropsychiatr Dis Treat. 2025 Oct 17;21:2321-2334. doi: 10.2147/NDT.S568794. eCollection 2025.

Hypoxic conditioning in Parkinson's disease: randomized controlled multiple N-of-1 trials

Janssen Daalen JM, Meinders MJ, Giardina F, Mathur S, Ainslie PN, Thijssen DHJ, Bloem BR.

Nat Commun. 2025 Sep 26;16(1):8469. doi: 10.1038/s41467-025-63324-2.

Staging and markers in Parkinson's disease and Lewy body disorders: narrative review

Bougea A.

Ther Adv Chronic Dis. 2025 Oct 22;16:20406223251381099. doi: 10.1177/20406223251381099. eCollection 2025.

Metabolic Parkinson's disease

Invernizzi F, Ciocca L, Contaldi E, Inverso D, Calandrella D, Mignone F, Barichella M, Isaias IU, Pezzoli G.

Front Aging Neurosci. 2025 Oct 10;17:1665957. doi: 10.3389/fnagi.2025.1665957. eCollection 2025.

Effects of Melatonin Disorders on Parkinson's Disease: A Review of Mechanisms and Clinical Manifestations

Shen Y, He C, Wang Y, Zhang Y, Liu Z, Chen X, Wang S, Bai Y.

Neuropsychiatr Dis Treat. 2025 Oct 18;21:2335-2355. doi: 10.2147/NDT.S536997. eCollection 2025.

Systematic review: digital biomarkers of fatigue in chronic diseases

Aboagye NY, Hinchliffe C, Del Din S, Ng WF, Baker KF, Baker MR.

NPJ Digit Med. 2025 Oct 8;8(1):602. doi: 10.1038/s41746-025-01939-x.

A systematic review and meta-analysis on glymphatic flow dysfunction in Parkinson's disease and Parkinsonism spectrum

Ghaderi S, Mohammadi S, Jouzdani AF, Ahmadzadeh AM, Fatehi F.

NPJ Parkinsons Dis. 2025 Oct 23;11(1):306. doi: 10.1038/s41531-025-01151-4.

Basal ganglia-brainstem interactions

Falasconi A, Arber S.

Curr Biol. 2025 Oct 20;35(20):R1004-R1010. doi: 10.1016/j.cub.2025.07.019.

Integrated multi-omics highlights alterations of gut microbiome functions in prodromal and idiopathic Parkinson's disease

Villette R, Ortís Sunyer J, Novikova PV, Aho VTE, Petrov VA, Hickl O, Busi SB, De Rudder C, Kunath BJ, Heintz-Buschart A, Trezzi JP, Halder R, Jäger C, Lebrun LA, Daujeumont A, Schade S, Janzen A, Jeh

Microbiome. 2025 Oct 7;13(1):200. doi: 10.1186/s40168-025-02227-2.

Cognitive stimulation in Parkinson's disease with mild cognitive impairment

Buonocore J, Iaccino N, Torchia G, Curcio F, Pirrotta FM, Contrada M, Pucci C, Gambardella A, Quattrone A, Pilotto A, Pignolo L, Arabia G.

J Neurol. 2025 Sep 27;272(10):658. doi: 10.1007/s00415-025-13374-9.

Role of Bioactive Compounds in Neuroprotection and Neurodegenerative Disease

Cantarero I, Del Río C.

Nutrients. 2025 Sep 26;17(19):3069. doi: 10.3390/nu17193069.

Anti-Neuroinflammatory and Anti-Inflammatory Effects of the NLRP3 Inhibitor NT-0796 in Subjects with Parkinson's Disease

Clarke N, Thornton P, Reader V, Lindsay N, Digby Z, Mullen B, Gorman M, Jacobson E, Langdon G, Johnstone H, Wheeler A, Watt AP.

Mov Disord. 2025 Oct;40(10):2199-2208. doi: 10.1002/mds.30307. Epub 2025 Aug 12.

Special Issue: "New Challenges of Parkinson's Disease"

Agliardi C, Guerini FR.

Int J Mol Sci. 2025 Sep 30;26(19):9564. doi: 10.3390/ijms26199564.